Trademark: 88751607
Status Date
Monday, September 4, 2023
Filing Date
Wednesday, January 8, 2020
Published for Opposition
Tuesday, June 9, 2020
Abandoned Date
Monday, September 4, 2023
5 Therapeutic preparations, namely, therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19, and therapeutic preparations for the prevention of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor
44 Providing health and medical information, and providing health and medical information in the nature of providing a website featuring information in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; providing a website featuring medical information; providing a website featuring medical information in the field of antibodies for use in targeting the CCR5 cell receptor; medical analysis services, namely, medical analysis services in the field of antibodies for use in targeting the CCR5 cell receptor, and medical analysis services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19
42 Scientific research consulting services, namely, scientific research consulting services in the field of immunology, and scientific research consulting services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services, and medical research services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services in the field of antibodies for use in targeting the CCR5 cell receptor
Sep 5, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Sep 4, 2023
Abandonment - No Use Statement Filed
Feb 8, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 7, 2023
Sou Extension 5 Granted
Jan 11, 2023
Sou Extension 5 Filed
Jan 26, 2023
Case Assigned To Intent To Use Paralegal
Jan 11, 2023
Sou Teas Extension Received
Jun 28, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 24, 2022
Sou Extension 4 Granted
Jun 24, 2022
Sou Extension 4 Filed
Jun 24, 2022
Sou Teas Extension Received
Feb 1, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 28, 2022
Sou Extension 3 Granted
Jan 28, 2022
Sou Extension 3 Filed
Jan 28, 2022
Sou Teas Extension Received
Jul 15, 2021
Notice Of Approval Of Extension Request E-Mailed
Jul 13, 2021
Sou Extension 2 Granted
Jul 13, 2021
Sou Extension 2 Filed
Jul 13, 2021
Sou Teas Extension Received
Jan 12, 2021
Notice Of Approval Of Extension Request E-Mailed
Jan 8, 2021
Sou Extension 1 Granted
Jan 8, 2021
Sou Extension 1 Filed
Jan 8, 2021
Sou Teas Extension Received
Aug 4, 2020
Noa E-Mailed - Sou Required From Applicant
Jun 9, 2020
Official Gazette Publication Confirmation E-Mailed
Jun 9, 2020
Published For Opposition
May 20, 2020
Notification Of Notice Of Publication E-Mailed
May 4, 2020
Assigned To Lie
Apr 24, 2020
Approved For Pub - Principal Register
Apr 24, 2020
Examiner's Amendment Entered
Apr 24, 2020
Notification Of Examiners Amendment E-Mailed
Apr 24, 2020
Examiners Amendment E-Mailed
Apr 24, 2020
Examiners Amendment -Written
Apr 22, 2020
Teas/Email Correspondence Entered
Apr 21, 2020
Correspondence Received In Law Office
Apr 21, 2020
Teas Response To Office Action Received
Mar 28, 2020
Notification Of Non-Final Action E-Mailed
Mar 28, 2020
Non-Final Action E-Mailed
Mar 28, 2020
Non-Final Action Written
Mar 26, 2020
Assigned To Examiner
Jan 13, 2020
New Application Office Supplied Data Entered
Jan 11, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
